Haleos Labs Limited (NSE:HALEOSLABS)
1,490.00
-11.40 (-0.76%)
Oct 1, 2026, 3:29 PM IST
Haleos Labs Market Cap
Haleos Labs has a market cap or net worth of 4.5 billion as of October 2, 2026. Its market cap has increased by 32.13% in one year.
Market Cap
4.50B
Enterprise Value
5.75B
Revenue
3.24B
Ranking
n/a
PE Ratio
28.51
Stock Price
1,490.00
ChartMarket Cap Chart
Since August 17, 2017, Haleos Labs's market cap has increased from 407.69M to 4.50B, an increase of 1,004.93%. That is a compound annual growth rate of 30.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 4.50B | 12.54% |
| Dec 31, 2025 | 4.00B | 12.59% |
| Dec 31, 2024 | 3.56B | 122.05% |
| Dec 29, 2023 | 1.60B | -15.33% |
| Dec 30, 2022 | 1.89B | -14.48% |
| Dec 31, 2021 | 2.21B | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 613.87B |
| Anthem Biosciences | 489.84B |
| OneSource Specialty Pharma | 181.52B |
| Concord Biotech | 147.58B |
| Blue Jet Healthcare | 104.03B |
| Supriya Lifescience | 79.28B |
| Zota Health Care | 45.03B |
| Dishman Carbogen Amcis | 25.30B |